Advisory: Research alert on Ascendant Resources withdrawn
(A research alert on Oppenheimer cutting its price target on Ascendant Resources ASND.TO is wrong and has been withdrawn. The brokerage cut its price target on Ascendis Pharma ASND.O , an unrelated company. For research alert on Ascendis Pharma, click urn:newsml:reuters.com:*:nFWN2D20NM) STORY_NUMBER: FWN2D2045 STORY_DATE: 20/05/2020 STORY_TIME: 09:48:50 ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Ascendis Pharma A/S
See all newsAscendis Pharma tumbles on Novo Nordisk collab termination
BioMarin climbs on global patent settlement with Ascendis
Brief: Ascendis Announces Oral Presentation Of Week 104 Data From Its Pivotal Trial Of Transcon® CNP (Navepegritide) At Isds 2026
Brief: Eyconis Announces Initiation Of First-In-Human Clinical Trial Of Eyc-0305 In Treatment-Naïve Wet Age-Related Macular Degeneration Patients
Ascendis Pharma A/S reports results for the quarter ended June 30 - Earnings Summary